Cargando…

Mycotic Keratitis—A Global Threat from the Filamentous Fungi

Mycotic or fungal keratitis (FK) is a sight-threatening disease, caused by infection of the cornea by filamentous fungi or yeasts. In tropical, low and middle-income countries, it accounts for the majority of cases of microbial keratitis (MK). Filamentous fungi, in particular Fusarium spp., the aspe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffman, Jeremy J., Burton, Matthew J., Leck, Astrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066744/
https://www.ncbi.nlm.nih.gov/pubmed/33916767
http://dx.doi.org/10.3390/jof7040273
_version_ 1783682640310697984
author Hoffman, Jeremy J.
Burton, Matthew J.
Leck, Astrid
author_facet Hoffman, Jeremy J.
Burton, Matthew J.
Leck, Astrid
author_sort Hoffman, Jeremy J.
collection PubMed
description Mycotic or fungal keratitis (FK) is a sight-threatening disease, caused by infection of the cornea by filamentous fungi or yeasts. In tropical, low and middle-income countries, it accounts for the majority of cases of microbial keratitis (MK). Filamentous fungi, in particular Fusarium spp., the aspergilli and dematiaceous fungi, are responsible for the greatest burden of disease. The predominant risk factor for filamentous fungal keratitis is trauma, typically with organic, plant-based material. In developed countries, contact lens wear and related products are frequently implicated as risk factors, and have been linked to global outbreaks of Fusarium keratitis in the recent past. In 2020, the incidence of FK was estimated to be over 1 million cases per year, and there is significant geographical variation; accounting for less than 1% of cases of MK in some European countries to over 80% in parts of south and south-east Asia. The proportion of MK cases is inversely correlated to distance from the equator and there is emerging evidence that the incidence of FK may be increasing. Diagnosing FK is challenging; accurate diagnosis relies on reliable microscopy and culture, aided by adjunctive tools such as in vivo confocal microscopy or PCR. Unfortunately, these facilities are infrequently available in areas most in need. Current topical antifungals are not very effective; infections can progress despite prompt treatment. Antifungal drops are often unavailable. When available, natamycin is usually first-line treatment. However, infections may progress to perforation in ~25% of cases. Future work needs to be directed at addressing these challenges and unmet needs. This review discusses the epidemiology, clinical features, diagnosis, management and aetiology of FK.
format Online
Article
Text
id pubmed-8066744
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80667442021-04-25 Mycotic Keratitis—A Global Threat from the Filamentous Fungi Hoffman, Jeremy J. Burton, Matthew J. Leck, Astrid J Fungi (Basel) Review Mycotic or fungal keratitis (FK) is a sight-threatening disease, caused by infection of the cornea by filamentous fungi or yeasts. In tropical, low and middle-income countries, it accounts for the majority of cases of microbial keratitis (MK). Filamentous fungi, in particular Fusarium spp., the aspergilli and dematiaceous fungi, are responsible for the greatest burden of disease. The predominant risk factor for filamentous fungal keratitis is trauma, typically with organic, plant-based material. In developed countries, contact lens wear and related products are frequently implicated as risk factors, and have been linked to global outbreaks of Fusarium keratitis in the recent past. In 2020, the incidence of FK was estimated to be over 1 million cases per year, and there is significant geographical variation; accounting for less than 1% of cases of MK in some European countries to over 80% in parts of south and south-east Asia. The proportion of MK cases is inversely correlated to distance from the equator and there is emerging evidence that the incidence of FK may be increasing. Diagnosing FK is challenging; accurate diagnosis relies on reliable microscopy and culture, aided by adjunctive tools such as in vivo confocal microscopy or PCR. Unfortunately, these facilities are infrequently available in areas most in need. Current topical antifungals are not very effective; infections can progress despite prompt treatment. Antifungal drops are often unavailable. When available, natamycin is usually first-line treatment. However, infections may progress to perforation in ~25% of cases. Future work needs to be directed at addressing these challenges and unmet needs. This review discusses the epidemiology, clinical features, diagnosis, management and aetiology of FK. MDPI 2021-04-03 /pmc/articles/PMC8066744/ /pubmed/33916767 http://dx.doi.org/10.3390/jof7040273 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hoffman, Jeremy J.
Burton, Matthew J.
Leck, Astrid
Mycotic Keratitis—A Global Threat from the Filamentous Fungi
title Mycotic Keratitis—A Global Threat from the Filamentous Fungi
title_full Mycotic Keratitis—A Global Threat from the Filamentous Fungi
title_fullStr Mycotic Keratitis—A Global Threat from the Filamentous Fungi
title_full_unstemmed Mycotic Keratitis—A Global Threat from the Filamentous Fungi
title_short Mycotic Keratitis—A Global Threat from the Filamentous Fungi
title_sort mycotic keratitis—a global threat from the filamentous fungi
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066744/
https://www.ncbi.nlm.nih.gov/pubmed/33916767
http://dx.doi.org/10.3390/jof7040273
work_keys_str_mv AT hoffmanjeremyj mycotickeratitisaglobalthreatfromthefilamentousfungi
AT burtonmatthewj mycotickeratitisaglobalthreatfromthefilamentousfungi
AT leckastrid mycotickeratitisaglobalthreatfromthefilamentousfungi